Skip to content
Trial Eligibility
Menu

Atopic Dermatitis (Eczema) Clinical Trials Recruiting in the US

69 studies for Atopic Dermatitis (Eczema) are recruiting at 535 US sites, according to ClinicalTrials.gov data processed .

Atopic dermatitis, the most common form of eczema, is a long-term skin condition that causes dry, itchy and inflamed skin.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Top Atopic Dermatitis (Eczema) studies by number of US sites

Showing 30 studies, most US recruiting sites first.
  1. A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

    NCT06389136

    • Phase 3
    • Ages 18 to 63 years
    • Sex: All
    Recruiting sites
    66 US recruiting sites
  2. This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

    NCT07290803

    • Observational
    • Ages 12 years and older
    • Sex: All
    Recruiting sites
    45 US recruiting sites
  3. A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

    NCT05995964

    • Phase 2
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    43 US recruiting sites
  4. Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

    NCT06988605

    • Observational
    • Ages 12 years and older
    • Sex: All
    Recruiting sites
    33 US recruiting sites
  5. Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

    NCT07298395

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All
    Recruiting sites
    32 US recruiting sites
  6. A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

    NCT06461897

    • Phase 3
    • Ages 2 to 11 years
    • Sex: All
    Recruiting sites
    26 US recruiting sites
  7. A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

    NCT07599813

    • Phase 2
    • Ages 18 to 65 years
    • Sex: All
    Recruiting sites
    25 US recruiting sites
  8. Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

    NCT06947993

    • Phase 2
    • Ages 18 to 100 years
    • Sex: All
    Recruiting sites
    24 US recruiting sites
  9. A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

    NCT07003425

    • Phase 2
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    23 US recruiting sites
  10. A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

    NCT07690371

    • Phase 3
    • Ages 12 years and older
    • Sex: All
    Recruiting sites
    19 US recruiting sites
  11. A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

    NCT07037901

    • Phase 2
    • Ages 18 to 74 years
    • Sex: All
    Recruiting sites
    16 US recruiting sites
  12. A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

    NCT06311682

    • Phase 3
    • Ages 6 months to 11 years
    • Sex: All
    Recruiting sites
    14 US recruiting sites
  13. A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

    NCT07216027

    • Phase 2
    • Ages 18 to 64 years
    • Sex: All
    Recruiting sites
    14 US recruiting sites
  14. A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

    NCT06807268

    • Phase 3
    • Ages 6 to 11 years
    • Sex: All
    Recruiting sites
    13 US recruiting sites
  15. A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

    NCT07711418

    • Phase 3
    • Ages 12 years and older
    • Sex: All
    Recruiting sites
    13 US recruiting sites
  16. Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

    NCT07645820

    • Observational
    • Ages 12 to 89 years
    • Sex: All
    Recruiting sites
    10 US recruiting sites
  17. A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

    NCT07643766

    • Phase 2
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    9 US recruiting sites
  18. A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

    NCT07765888

    • Phase 3
    • Ages 12 years and older
    • Sex: All
    Recruiting sites
    8 US recruiting sites
  19. Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

    NCT06504160

    • Phase 1
    • Ages 6 years and older
    • Sex: All
    Recruiting sites
    7 US recruiting sites
  20. A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

    NCT06807281

    • Phase 3
    • Ages 2 to 11 years
    • Sex: All
    Recruiting sites
    7 US recruiting sites
  21. Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

    NCT06397911

    • Phase 2
    • Ages 18 to 65 years
    • Sex: All
    Recruiting sites
    6 US recruiting sites
  22. Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

    NCT07453602

    • Phase 1
    • Ages 18 to 65 years
    • Sex: All
    • Accepts healthy volunteers
    Recruiting sites
    6 US recruiting sites
  23. First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

    NCT07527923

    • Phase 1
    • Ages 18 to 65 years
    • Sex: All
    • Accepts healthy volunteers
    Recruiting sites
    6 US recruiting sites
  24. A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis

    NCT07558668

    • Phase 1
    • Ages 18 to 65 years
    • Sex: All
    • Accepts healthy volunteers
    Recruiting sites
    6 US recruiting sites
  25. A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

    NCT07783425

    • Phase 3
    • Ages 12 years and older
    • Sex: All
    Recruiting sites
    6 US recruiting sites
  26. FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

    NCT06564389

    • Phase 1
    • Ages 18 to 70 years
    • Sex: All
    • Accepts healthy volunteers
    Recruiting sites
    5 US recruiting sites
  27. A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis

    NCT06055361

    • Phase 1
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    3 US recruiting sites
  28. A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

    NCT06808477

    • Phase 1
    • Ages 18 to 72 years
    • Sex: All
    • Accepts healthy volunteers
    Recruiting sites
    3 US recruiting sites
  29. A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

    NCT06524635

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All
    Recruiting sites
    2 US recruiting sites
  30. Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

    NCT06982352

    • Phase 1
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    2 US recruiting sites

By city

Atopic Dermatitis (Eczema) clinical trials by city

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining an Atopic Dermatitis (Eczema) clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.